Human fortilin is a molecular target of dihydroartemisinin |
| |
Authors: | Fujita Takayuki Felix Kumar Pinkaew Decha Hutadilok-Towatana Nongporn Liu Zhihe Fujise Ken |
| |
Affiliation: | Division of Cardiology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA. |
| |
Abstract: | Dehydroartemisinin (DHA) is an effective anti-malaria agent. Fortilin is an anti-apoptotic molecule overexpressed in many human cancers. Here, we show that DHA binds human fortilin, increases the ubiquitination of fortilin, shortens fortilin's half-life in a proteasome-dependent fashion, and reduces cellular levels of fortilin in varieties of cells. DHA induced DNA fragmentation in U2OS cells in a fortilin-dependent manner. The fortilin-knocked-down cells were less susceptible--and fortilin-overexpressing cells more susceptible--to DHA than were wild-type cells, suggesting that apoptotic effects of DHA are-at least partly-conferred through fortilin. Together, these data suggest that fortilin is a molecular target of DHA. DHA and its derivative may prove to be viable anti-cancer agents in fortilin-overexpressing cancers. |
| |
Keywords: | DHA, dihydroartemisinin TCTP, translationally controlled tumor protein HRP, histamine releasing factor ANOVA, analysis of variance SPR, surface plasmon resonance |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|